LRVHealth, McKesson Ventures, Novartis, Hearst Ventures, Onco360, and HealthX Ventures Join Investment Round to Redefine Specialty Patient Access and OnboardingNEW ALBANY, Ind.--(BUSINESS WIRE)--#medaccess--RxLightning, creator of the industry’s first...
Strategic Healthcare Venture Capital Platform Connects Largest Network of Healthcare Incumbents with Entrepreneurs Addressing the Industry’s Biggest Challenges & OpportunitiesBOSTON--(BUSINESS WIRE)--LRVHealth, the inside healthcare venture capita...
Investment further validates Amino Health’s model for making healthcare more intuitive, accessible and convenient through its transformative healthcare guidance solutionSAN FRANCISCO--(BUSINESS WIRE)--Amino Health, the leading digital healthcare guida...
Traction gained in clinical trials enables Autonomize AI to launch new generative-AI and clinical large-language-model-based solutions to improve patient outcomes Autonomize AI products organize, contextualize and summarize unstructured data so non-...
Grant will support platform development and artificial intelligence model creation to generate the most comprehensive set of algorithms for malaria rapid diagnostic testsSEATTLE--(BUSINESS WIRE)--#globalhealth--Audere, a global digital health non-prof...
To commercialize Toku’s artificial intelligence platform that analyzes retinal images to detect cardiovascular disease and other potential health risksDULUTH, Ga.--(BUSINESS WIRE)--Toku Inc., a leader in applying AI-powered diagnostic and screening to...
DALLAS--(BUSINESS WIRE)--Recuro Health (Recuro), an integrated digital health solutions company designed to transition the U.S. healthcare system from a reactive, disease-focused model to a proactive care approach, today announces the closing of a $47 ...
Funding will support platform roll out to accelerate the loan origination process for lenders and borrowers NEW YORK--(BUSINESS WIRE)--Presta, an end-to-end digital lending platform that modernizes and accelerates the loan origination process, announc...
PARIS & NEW YORK--(BUSINESS WIRE)--Inato, the leading technology platform enabling access to inclusive clinical trials, today announced the close of $20 million in Series A2 funding from existing and new investors. The fundraise includes return and lea...
Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--#ISO27001--Genialis, a computational precision medicine company ...